These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 30036192)

  • 1. Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus ventilator-associated pneumonia.
    Luyt CE; Hékimian G; Koulenti D; Chastre J
    Curr Opin Crit Care; 2018 Oct; 24(5):332-338. PubMed ID: 30036192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic treatment of hospital-acquired pneumonia: is it different from ventilator-associated pneumonia?
    Niederman MS
    Curr Opin Crit Care; 2018 Oct; 24(5):353-360. PubMed ID: 30028739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
    Barbier F; Andremont A; Wolff M; Bouadma L
    Curr Opin Pulm Med; 2013 May; 19(3):216-28. PubMed ID: 23524477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe.
    Martin-Loeches I; Rodriguez AH; Torres A
    Curr Opin Crit Care; 2018 Oct; 24(5):347-352. PubMed ID: 30063491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of ICU-acquired pneumonia.
    Ferrer M; Torres A
    Curr Opin Crit Care; 2018 Oct; 24(5):325-331. PubMed ID: 30080701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare-Associated Pneumonia and Hospital-Acquired Pneumonia: Bacterial Aetiology, Antibiotic Resistance and Treatment Outcomes: A Study From North India.
    Kumar S; Jan RA; Fomda BA; Rasool R; Koul P; Shah S; Khan UH; Qadri SM; Masoodi SR; Mantoo S; Muzamil M
    Lung; 2018 Aug; 196(4):469-479. PubMed ID: 29691645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a multiplex molecular pneumonia panel and real-world impact on antimicrobial stewardship among patients with hospital-acquired and ventilator-associated pneumonia in intensive care units.
    Chen CL; Tseng HY; Chen WC; Liang SJ; Tu CY; Lin YC; Hsueh PR
    J Microbiol Immunol Infect; 2024 Jun; 57(3):480-489. PubMed ID: 38471985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging trends of nosocomial pneumonia in intensive care unit of a tertiary care public teaching hospital in Western India.
    Bhadade R; Harde M; deSouza R; More A; Bharmal R
    Ann Afr Med; 2017; 16(3):107-113. PubMed ID: 28671150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit.
    Djordjevic ZM; Folic MM; Jankovic SM
    J Infect Public Health; 2017; 10(6):740-744. PubMed ID: 28189513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram-negative pathogens: a multicenter retrospective cohort study.
    Barbier F; Dupuis C; Buetti N; Schwebel C; Azoulay É; Argaud L; Cohen Y; Hong Tuan Ha V; Gainnier M; Siami S; Forel JM; Adrie C; de Montmollin É; Reignier J; Ruckly S; Zahar JR; Timsit JF;
    Crit Care; 2024 Jan; 28(1):10. PubMed ID: 38172969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Algorithm to Analyze Epidemiology and Outcomes of Carbapenem Resistance Among Patients With Hospital-Acquired and Ventilator-Associated Pneumonia: A Retrospective Cohort Study.
    Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
    Chest; 2019 Jun; 155(6):1119-1130. PubMed ID: 30685333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs.
    Borgatta B; Gattarello S; Mazo CA; Imbiscuso AT; Larrosa MN; Lujàn M; Rello J
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2155-2163. PubMed ID: 28624864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriological profile of ventilator-associated pneumonia in a tertiary care hospital.
    Patro S; Sarangi G; Das P; Mahapatra A; Mohapatra D; Paty BP; Chayani N
    Indian J Pathol Microbiol; 2018; 61(3):375-379. PubMed ID: 30004058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, comparative clinical study between high-dose colistin monotherapy and colistin-meropenem combination therapy for treatment of hospital-acquired pneumonia and ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae.
    Abdelsalam MFA; Abdalla MS; El-Abhar HSE
    J Glob Antimicrob Resist; 2018 Dec; 15():127-135. PubMed ID: 30010061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
    Pugh R; Grant C; Cooke RP; Dempsey G
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007577. PubMed ID: 26301604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria.
    Cillóniz C; Dominedò C; Torres A
    Curr Opin Infect Dis; 2019 Dec; 32(6):656-662. PubMed ID: 31567412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia.
    Kaye KS; Udeani G; Cole P; Friedland HD
    Hosp Pract (1995); 2015; 43(3):144-9. PubMed ID: 25956849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015.
    Wałaszek M; Różańska A; Wałaszek MZ; Wójkowska-Mach J;
    BMC Infect Dis; 2018 Jul; 18(1):308. PubMed ID: 29976151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.